University of Texas Southwestern Medical Center - Simmons Cancer Center, Dallas
University of Texas Southwestern Medical Center-William P. Clements Jr. University Hospital, Dallas
University of Texas Southwestern Medical Center-Zale Lipshy University Hospital, Dallas
at 3 pa

Nagre-recruitPhase 2/3

Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06989437

A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms

MD Anderson Cancer Center, Houston

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06150157

A Study of NEOK001, a B7-H3 and ROR1 Targeting Bispecific ADC in Participants With Select Solid Tumors

NEXT Oncology, Austin
NEXT Oncology, Dallas
SCRI at Mary Crowley, Dallas
at 3 pa

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07612176

A Study of MK-5684 in People With Certain Solid Tumors (MK-5684-015/OMAHA-015)

Baylor College of Medicine Medical Center ( Site 0004), Houston
Harris Health System ( Site 0040), Houston
Mays Cancer Center ( Site 0039), San Antonio

Nagre-recruitPhase 2

Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06979596

A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01)

University of Texas M.D. Anderson Cancer Center ( Site 4007), Houston

Nagre-recruitPhase 1/2

1 Month – 17 Years · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07630974

A Study of GSK5764227 in Combination With Standard of Care (SoC) or Other Agents in Participants With Advanced Solid Tumors

GSK Investigational Site, Dallas

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07277270

A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)

Oncology Consultants PA, Houston
University of Texas MD Anderson Cancer Center, Houston
US Oncology Research Investigational Products Center, Irving

Nagre-recruitPhase 3

Edad 18 hanggang 100 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT05920356

A Study of JNJ-87704916, as Monotherapy and in Combination for Advanced Solid Tumors

MD Anderson Cancer Center, Houston

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06311578

First Time in Human (FTIH) Study to Investigate the Safety and Preliminary Activity of GSK5533524 Alone or in Combination in Adult Participants With Advanced Solid Tumors

GSK Investigational Site, San Antonio

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07438782

A Study of JNJ-1761981 in Participants With Solid Tumors

MD Anderson Cancer Center, Houston

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07525141

Pilot Study of Management of Facial Paralysis in the Oncologic Patient: Nerve Transfer Techniques to Improve Facial Function and Quality of Life

The University of Texas M. D. Anderson Cancer Center, Houston

Nagre-recruit

Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06667427

Clinical Study of MK-4884 in Participants With Advanced or Metastatic Solid Tumors (MK-4884-001)

NEXT Oncology ( Site 0151), San Antonio

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07600749

A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer

Texas Oncology-Baylor Charles A Sammons Cancer Center, Dallas
The Center For Cancer And Blood Disorders (Texas Cancer Care), Fort Worth
Houston Methodist Cancer Center, Houston

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Set 24, 2026 · NCT06901531

Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia

Quetzal Site 6, Houston

Nagre-recruitPhase 3

Edad 18 hanggang 71 · Lahat ng kasarian · Na-update Set 23, 2026 · NCT07504458

A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer

The University of Texas MD Anderson Cancer Center /ID# 280070, Houston
Texas Oncology - Northeast Texas /ID# 280642, Tyler

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Set 23, 2026 · NCT07365241

Extension Study for Participants in Studies That Include Belzutifan (MK-6482-043/LITESPARK-043)

START San Antonio ( Site 0104), San Antonio

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Set 23, 2026 · NCT07405164

Intratumoral N17350 in Advanced Solid Tumors

The University of Texas MD Anderson Cancer Center, Houston

Nagre-recruitPhase 1/2

Edad 18 pataas · Lahat ng kasarian · Na-update Set 23, 2026 · NCT07339176

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

MD Anderson, Houston
NEXT Dallas, Irving
NEXT Oncology San Antonio, San Antonio
at 1 pa

Nagre-recruitPhase 1/2

Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT06128551

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

The University of Texas MD Anderson Cancer Center, Houston

Nagre-recruitPhase 2

Edad 12 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT02693535

Prospective Study to Assess a Diagnostic Aid for Cancer

Premier Family Physicians, Austin
Texas Digestive, Harlingen
Huntsville Research Institute, LLC, Huntsville
at 1 pa

Nagre-recruitObservasyonal na pag-aaral

Edad 45 pataas · Lahat ng kasarian · Na-update Set 21, 2026 · NCT07046260

Perceptions of Hospital Care at Home for Patients With Cancer: A Qualitative Study of Cancer Providers, Patients and Caregivers.

M D Anderson Cancer Center, Houston

Nagre-recruitObservasyonal na pag-aaral

Edad 18 pataas · Lahat ng kasarian · Na-update Set 18, 2026 · NCT05694650

Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells

Texas Oncology, Dallas
Texas Oncology - Baylor Charles A. Sammons Cancer Center, Dallas
UT Southwestern Medical Center, Dallas
at 3 pa

Nagre-recruitPhase 2/3

Lahat ng edad · Lahat ng kasarian · Na-update Set 18, 2026 · NCT03435796

Bone Marrow Imaging and Clinical Outcomes Across Hematologic, Oncologic, and Other Relevant Conditions

UT MD Anderson Cancer Center, Houston

Nagre-recruitObservasyonal na pag-aaral

Lahat ng edad · Lahat ng kasarian · Na-update Set 18, 2026 · NCT07743476

A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)

University of Texas-MD Anderson Cancer Center ( Site 3007), Houston

Nagre-recruitPhase 1/2

1 Month – 17 Years · Lahat ng kasarian · Na-update Set 17, 2026 · NCT06941272

Connect for Cancer Prevention Study (Connect)

Baylor Scott and White Health, Dallas

Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo

Edad 30 hanggang 70 · Lahat ng kasarian · Na-update Set 17, 2026 · NCT04609072

Statins to Prevent Cancer Associated Blood Clots

The University of Texas MD Anderson Cancer Center, Houston

Nagre-recruitPhase 4

Edad 18 pataas · Lahat ng kasarian · Na-update Set 16, 2026 · NCT07303816

Replacing Invasive Cystoscopy With Urine Testing for Non-muscle Invasive Bladder Cancer Surveillance

UT Southwestern Medical Center, Dallas

Nagre-recruitPhase 2

Edad 18 pataas · Lahat ng kasarian · Na-update Set 16, 2026 · NCT05796375

Mula sa ClinicalTrials.gov, na-kuha noong Okt 1, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.